Shares in the Egyptian lab group Integrated Diagnostic Holdings (IDH) have rocketed 35% to $6 per share in the two weeks since its IPO in London. The IPO at the very top of its indicative price range, valued IDH at 13.8 times 2014 EBITDA. It is now worth over $900m – a historic EBITDA multiple of 17.